About JGR Capital
JGR Capital is an international equity research focused on covering under followed public companies with a market cap less than $2 billion. We are headquartered in New York City, with affiliate offices in Shanghai and São Paulo. Our team of experienced analysts form investment theses based on company and sector expertise, with a strict focus on fundamentals and valuation.
Our analysts gather the latest information for our reports by utilizing the best technologies including Bloomberg and FactSet. We strive to help our clients by attracting liquidity, gaining access to capital, and achieving a fair valuation.
This page is dedicated to the press announcement for JGR Capital’s KaloBios Pharmaceuticals Initial Coverage Report (KBIO).
JGR Capital’s full KaloBios Pharmaceuticals Initial Coverage Report can be found here:
This page is dedicated to the press announcement of JGR Capital’s Zivo Bioscience Initial Coverage (ZIVO).
The full report is available at this PDF link:
New York, NY, February 13, 2017 –(PR.com)– JGR Capital Partners, a leading equity research and digital investor relations firm, has announced it has released an update on BioCorRx (OTC PINK: BICX).
The full report can be found at www.jgrcapitalpartners.com
BioCorRx working with Innovative Science Solutions for regulatory matters
BioCorRx Inc. announced […]
NEW YORK, NY / ACCESSWIRE / January 19, 2017 / JGR Capital Partners, a leading equity research and digital investor relations firm, has announced it has initiated coverage on BioCorRx (OTC PINK: BICX) with a price target of $0.09.
The full report can be found here: BICX Initiation
BioCorRx operates in […]